112 related articles for article (PubMed ID: 25005584)
21. Enhanced oral bioavailability of Tanshinone IIA using lipid nanocapsules: Formulation, in-vitro appraisal and pharmacokinetics.
Ashour AA; Ramadan AA; Abdelmonsif DA; El-Kamel AH
Int J Pharm; 2020 Aug; 586():119598. PubMed ID: 32629068
[TBL] [Abstract][Full Text] [Related]
22. Characterisation and Skin Distribution of Lecithin-Based Coenzyme Q10-Loaded Lipid Nanocapsules.
Zhou H; Yue Y; Liu G; Li Y; Zhang J; Yan Z; Duan M
Nanoscale Res Lett; 2010 Jul; 5(10):1561-9. PubMed ID: 21076708
[TBL] [Abstract][Full Text] [Related]
23. Formulation and development of bioadhesive transdermal gel of ropivacaine loaded nanoparticles for enhancement of anesthetic effect: Preclinical study in animal model.
Chang Song Li -; Lu Chen -; De Chen -; Shaonan Wang -
Pak J Pharm Sci; 2023 May; 36(3):843-848. PubMed ID: 37580933
[TBL] [Abstract][Full Text] [Related]
24. Ocular permeability, intraocular biodistribution of lipid nanocapsule formulation intended for retinal drug delivery.
Christensen G; Urimi D; Lorenzo-Soler L; Schipper N; Paquet-Durand F
Eur J Pharm Biopharm; 2023 Jun; 187():175-183. PubMed ID: 37088247
[TBL] [Abstract][Full Text] [Related]
25. Lipid nanocapsules functionalized with polyethyleneimine for plasmid DNA and drug co-delivery and cell imaging.
Skandrani N; Barras A; Legrand D; Gharbi T; Boulahdour H; Boukherroub R
Nanoscale; 2014 Jul; 6(13):7379-90. PubMed ID: 24871584
[TBL] [Abstract][Full Text] [Related]
26. Lipid nanocarriers improve paclitaxel transport throughout human intestinal epithelial cells by using vesicle-mediated transcytosis.
Roger E; Lagarce F; Garcion E; Benoit JP
J Control Release; 2009 Dec; 140(2):174-81. PubMed ID: 19699246
[TBL] [Abstract][Full Text] [Related]
27. EGFR siRNA lipid nanocapsules efficiently transfect glioma cells in vitro.
Resnier P; David S; Lautram N; Delcroix GJ; Clavreul A; Benoit JP; Passirani C
Int J Pharm; 2013 Oct; 454(2):748-55. PubMed ID: 23583841
[TBL] [Abstract][Full Text] [Related]
28. Nose to brain delivery of mirtazapine via lipid nanocapsules: Preparation, statistical optimization, radiolabeling, in vivo biodistribution and pharmacokinetic study.
Ibrahim MM; Basalious EB; El-Nabarawi MA; Makhlouf AI; Sayyed ME; Ibrahim IT
Drug Deliv Transl Res; 2024 Feb; ():. PubMed ID: 38376620
[TBL] [Abstract][Full Text] [Related]
29. Inner ear biocompatibility of lipid nanocapsules after round window membrane application.
Zhang Y; Zhang W; Löbler M; Schmitz KP; Saulnier P; Perrier T; Pyykkö I; Zou J
Int J Pharm; 2011 Feb; 404(1-2):211-9. PubMed ID: 21075187
[TBL] [Abstract][Full Text] [Related]
30. Surface active properties of lipid nanocapsules.
Mouzouvi CRA; Umerska A; Bigot AK; Saulnier P
PLoS One; 2017; 12(8):e0179211. PubMed ID: 28796777
[TBL] [Abstract][Full Text] [Related]
31. Modified Lipid Nanocapsules for Targeted Tanshinone IIA Delivery in Liver Fibrosis.
Ashour AA; El-Kamel AH; Abdelmonsif DA; Khalifa HM; Ramadan AA
Int J Nanomedicine; 2021; 16():8013-8033. PubMed ID: 34916792
[TBL] [Abstract][Full Text] [Related]
32. Lipid Nanocapsules for Imatinib Delivery: Design, Optimization and Evaluation of Anticancer Activity Against Melanoma Cell Line.
Molaahmadi MR; Varshosaz J; Taymouri S; Akbari V
Iran J Pharm Res; 2019; 18(4):1676-1693. PubMed ID: 32184838
[TBL] [Abstract][Full Text] [Related]
33. Lipid nanocapsules: a new platform for nanomedicine.
Huynh NT; Passirani C; Saulnier P; Benoit JP
Int J Pharm; 2009 Sep; 379(2):201-9. PubMed ID: 19409468
[TBL] [Abstract][Full Text] [Related]
34. Distribution of lipid nanocapsules in different cochlear cell populations after round window membrane permeation.
Zou J; Saulnier P; Perrier T; Zhang Y; Manninen T; Toppila E; Pyykkö I
J Biomed Mater Res B Appl Biomater; 2008 Oct; 87(1):10-8. PubMed ID: 18437698
[TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetics of intact lipid nanocapsules using new quantitative FRET technique.
Lebreton V; Kaeokhamloed N; Vasylaki A; Hilairet G; Mellinger A; Béjaud J; Saulnier P; Lagarce F; Gattacceca F; Legeay S; Roger E
J Control Release; 2022 Nov; 351():681-691. PubMed ID: 36191672
[TBL] [Abstract][Full Text] [Related]
36. Cytotoxicity and genotoxicity of lipid nanocapsules.
Le Roux G; Moche H; Nieto A; Benoit JP; Nesslany F; Lagarce F
Toxicol In Vitro; 2017 Jun; 41():189-199. PubMed ID: 28323104
[TBL] [Abstract][Full Text] [Related]
37. Development and in vitro evaluation of a novel lipid nanocapsule formulation of etoposide.
Saliou B; Thomas O; Lautram N; Clavreul A; Hureaux J; Urban T; Benoit JP; Lagarce F
Eur J Pharm Sci; 2013 Oct; 50(2):172-80. PubMed ID: 23831519
[TBL] [Abstract][Full Text] [Related]
38. Low temperature, easy scaling up method for development of smart nanostructure hybrid lipid capsules for drug delivery application.
Yadava SK; Basu SM; Chauhan M; Sharma K; Pradhan A; V R; Giri J
Colloids Surf B Biointerfaces; 2020 Jun; 190():110927. PubMed ID: 32169777
[TBL] [Abstract][Full Text] [Related]
39. Lipid nanocapsules as in vivo oxygen sensors using magnetic resonance imaging.
Nel J; Franconi F; Joudiou N; Saulnier P; Gallez B; Lemaire L
Mater Sci Eng C Mater Biol Appl; 2019 Aug; 101():396-403. PubMed ID: 31029333
[TBL] [Abstract][Full Text] [Related]
40. Physicochemical Characterization of Ferrocifen Lipid Nanocapsules: Customized Drug Delivery Systems Guided by the Molecular Structure.
Idlas P; Lepeltier E; Bastiat G; Pigeon P; McGlinchey MJ; Lautram N; Vessières A; Jaouen G; Passirani C
Langmuir; 2023 Feb; 39(5):1885-1896. PubMed ID: 36693216
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
